Astrana Health (NASDAQ:ASTH) Hits New 52-Week High - Time to Buy?

Key Points

• Astrana Health hit a new 52-week high of $35.79 and was last trading around $35.70 on volume of 71,121 shares.
• The company reported a strong quarter with $0.54 EPS vs. $0.15 consensus and revenue of $950.53 million, up 42.9% year‑over‑year.
• Analysts are broadly positive (six Buys, three Holds) with a MarketBeat consensus of a "Moderate Buy" and a consensus target price of $34.86, while the stock has a market cap of $1.95 billion and a PE of 76.05.

Astrana Health, Inc. (NASDAQ:ASTH - Get Free Report) hit a new 52-week high during trading on Monday . The company traded as high as $35.79 and last traded at $35.7040, with a volume of 71121 shares trading hands. The stock had previously closed at $34.89.

Analyst Ratings Changes

ASTH has been the topic of a number of recent research reports. BTIG Research dropped their price target on Astrana Health from $45.00 to $40.00 and set a "buy" rating on the stock in a research report on Monday, February 2nd. Zacks Research raised Astrana Health from a "strong sell" rating to a "hold" rating in a research report on Wednesday, March 11th. Truist Financial increased their price objective on Astrana Health from $37.00 to $38.00 and gave the stock a "buy" rating in a report on Friday, March 13th. Robert W. Baird increased their price objective on Astrana Health from $37.00 to $40.00 and gave the stock an "outperform" rating in a report on Wednesday, April 15th. Finally, Weiss Ratings raised Astrana Health from a "sell (d+)" rating to a "hold (c-)" rating in a report on Wednesday. Six investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $34.86.

Astrana Health Trading Up 0.3%

The firm has a fifty day simple moving average of $26.43 and a two-hundred day simple moving average of $25.58. The stock has a market cap of $1.95 billion, a PE ratio of 76.05 and a beta of 0.98. The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 1.25.

Astrana Health (NASDAQ:ASTH - Get Free Report) last released its quarterly earnings results on Monday, March 2nd. The company reported $0.54 earnings per share for the quarter, beating the consensus estimate of $0.15 by $0.39. Astrana Health had a return on equity of 5.59% and a net margin of 0.71%.The firm had revenue of $950.53 million for the quarter, compared to analysts' expectations of $930.46 million. During the same quarter last year, the firm posted ($0.15) EPS. The company's revenue was up 42.9% compared to the same quarter last year. As a group, equities analysts expect that Astrana Health, Inc. will post 1.44 earnings per share for the current fiscal year.

Institutional Trading of Astrana Health

Several institutional investors and hedge funds have recently modified their holdings of ASTH. Signaturefd LLC raised its holdings in shares of Astrana Health by 57.9% in the 4th quarter. Signaturefd LLC now owns 1,058 shares of the company's stock valued at $26,000 after acquiring an additional 388 shares in the last quarter. GAMMA Investing LLC increased its position in shares of Astrana Health by 144.7% during the 4th quarter. GAMMA Investing LLC now owns 1,473 shares of the company's stock valued at $37,000 after purchasing an additional 871 shares during the last quarter. Strs Ohio bought a new position in shares of Astrana Health during the 4th quarter valued at about $40,000. Covestor Ltd increased its position in shares of Astrana Health by 210.6% during the 3rd quarter. Covestor Ltd now owns 3,233 shares of the company's stock valued at $92,000 after purchasing an additional 2,192 shares during the last quarter. Finally, Tower Research Capital LLC TRC increased its position in shares of Astrana Health by 323.3% during the 2nd quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company's stock valued at $115,000 after purchasing an additional 3,517 shares during the last quarter. Hedge funds and other institutional investors own 52.77% of the company's stock.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.